SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abbott Japan and Eisai Company, Ltd. Receive Approval to Market the Pancreatic Digestive Enzyme Replacement Drug Lipacreon(R) (pancrelipase) in Japan